Logo
  • About
  • Contact
  • (888) 441-8033

GaN Systems and Axign Announce the “Coolest” 1000W Class D Audio Amplifier Design Unveiling at CES 2023

OTTAWA, Canada – January 4, 2023 – GaN Systems, the global leader in GaN power semiconductors, and Axign, the fabless semiconductor company delivering breakthrough analog/mixed-signal technology and ICs for audio amplifier systems, unveiled a revolutionary 1000W Class-D GaN au...

View full release

Carmine Therapeutics: Gene Therapy 3.0

Carmine Therapeutics is developing allogeneic, redosable, non-viral gene therapies to treat diseases for which a high unmet medical need exists. The company’s technology harnesses the natural properties of human red blood cells (RBCs) to produce extracellular vesicles (EVs), a...

View full release

2022 BIO Report Ranks Utah in the Top Eight States for Bioscience Specialization

Salt Lake City - December 27, 2022. BioUtah, Utah’s only trade association dedicated solely to the life sciences, announced today new economic data released by the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations on the bioscience in...

View full release

FMC Technologies Ushers in 25 Years of Building Energy Solutions

CHELMSFORD (December 22, 2022) — There are a lot of conversations surrounding energy in the news lately, spanning from climate change to energy allocation to de-carbonization all resulting in the ever-growing cost to heat, cool and ventilate commercial buildings.  With that ba...

View full release

Material Opportunities in Electrification Webinar: Stonegate Research Note

DALLAS, TX -- December 20th, 2022 -- Stonegate Capital Partners On December 14th, 2022, Stonegate Capital Partners held its Material Opportunities in Electrification Webinar. The panelists included Alberto Arias from Largo (NasdaqGS:LGO), Eduardo Covarrubias from Los Andes Cop...

View full release

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (Nasdaq:BPTH) Q3 '22

DALLAS, TX -- December 19th, 2022 --  Bio-Path Holdings, Inc. (Nasdaq:BPTH): The full report can be accessed by clicking on the following link: https://stonegateinc.com/reports/BPTH_Q322.pdf Additional Progress in Q322 – Strong Pipeline Owning the Breakthrough Technology: Bio...

View full release

Ceres Holographics recognized as one of the most promising technology companies at TechTour Photonics & Electronics 2022

LIVINGSTON, Scotland, UK – December 19, 2022 - Ceres Holographics, an innovative developer of precision engineered Holographic Optical Elements (HOEs) in advanced photopolymer, was named one of the top presenters at the recent Photonics & Electronics 2022 investment event held...

View full release

InFlectis BioScience Doses First Patient with IFB-088 in a Phase 2 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis

Nantes, France, December 19, 2022: InFlectis BioScience SAS, a clinical-stage company developing innovative therapeutics for neuromuscular diseases by harnessing the Integrated Stress Response (ISR), dosed the first patient with IFB-088 in combination with riluzole as part of ...

View full release

Stonegate Capital Partners Updates Coverage on Eagle Financial Services, Inc. (OTCQX: EFSI) Q3 2022

DALLAS, TX -- December 15th, 2022 -- Eagle Financial Services, Inc (OTCQX:EFSI): Stonegate Capital Partners updates coverage on Eagle Financial Services, Inc (OTCQX:EFSI). The full report can be accessed by clicking on the following link: https://stonegateinc.com/reports/EFSI_...

View full release

Stonegate Capital Partners Updates Coverage on Pathfinder Bancorp, Inc. (Nasdaq:PBHC) Q3 2022

DALLAS, TX -- December 14th, 2022 --  Pathfinder Bancorp, Inc. (Nasdaq:PBHC): The full report can be accessed by clicking on the following link: https://stonegateinc.com/reports/PBHC_3Q22.pdf COMPANY DESCRIPTION Pathfinder Bancorp operates as a holding company that owns Pathf...

View full release
  • « First
  • ‹ Prev
  • …
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • …
  • Next ›
  • Last »
©2026 Reportable, Inc.
Terms and Conditions | Privacy Policy